Concepedia

Megan Duggan

MD

Statistics

Publications

21

Citations

1.3K

H-Index

16

Active since

2014

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

The Ohio State University Wexner Medical Center

Ohio Department of Mental Health & Addiction Services

Ohio State University Hospital

Megan Duggan is an author at The Ohio State University specializing in oncology, cancer immunology, and cancer immunotherapy.

Publications per year

2014–2023

21

Publications

21

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function

Andrew Stiff, Prashant Trikha, Bethany L. Mundy-Bosse et al. · Clinical Cancer Research · 2018 · 236 citations · Full text

, , +17

Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment

Andrew Stiff, Prashant Trikha, Robert Wesolowski et al. · Cancer Research · 2016 · 183 citations · Full text

, , +16

Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro

Brooke Benner, Luke Scarberry, Lorena P. Suarez‐Kelly et al. · Journal for ImmunoTherapy of Cancer · 2019 · 182 citations · Full text

, , +16

Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease

Joseph Markowitz, Taylor Brooks, Megan Duggan et al. · Cancer Immunology Immunotherapy · 2014 · 123 citations · Full text

, , +14

Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors

Xiulan Lai, Andrew Stiff, Megan Duggan et al. · Proceedings of the National Academy of Sciences · 2018 · 112 citations · Full text

, , +17

1–5 of 21